lobbying_activities: 2513668

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2513668	fa094052-2b40-415d-8663-98c03a718cb0	Q3	FORBES-TATE	400976792	NOVARTIS, INC.	2020	third_quarter	CPT	Issues related to prescription drug pricing, the United States-Mexico-Canada Agreement (USMCA), and Intellectual Property (IP); Issues related to H.R. 748 - the CARES Act (Pub.L. 116-136).	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2020-10-18T15:35:38.930000-04:00